• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA作为多发性硬化症中T淋巴细胞的调节因子

MicroRNAs as T Lymphocyte Regulators in Multiple Sclerosis.

作者信息

Wang Lin, Liang Yuanyuan

机构信息

Department of Emergency Medicine, Shengjing Hospital of China Medical University, Shenyang, China.

出版信息

Front Mol Neurosci. 2022 Apr 25;15:865529. doi: 10.3389/fnmol.2022.865529. eCollection 2022.

DOI:10.3389/fnmol.2022.865529
PMID:35548667
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9082748/
Abstract

MicroRNA (miRNA) is a class of endogenous non-coding small RNA with regulatory activities, which generally regulates the expression of target genes at the post-transcriptional level. Multiple Sclerosis (MS) is thought to be an autoimmune-mediated chronic inflammatory demyelinating disease of the central nervous system (CNS) that typically affect young adults. T lymphocytes play an important role in the pathogenesis of MS, and studies have suggested that miRNAs are involved in regulating the proliferation, differentiation, and functional maintenance of T lymphocytes in MS. Dysregulated expression of miRNAs may lead to the differentiation balance and dysfunction of T lymphocytes, and they are thus involved in the occurrence and development of MS. In addition, some specific miRNAs, such as miR-155 and miR-326, may have potential diagnostic values for MS or be useful for discriminating subtypes of MS. Moreover, miRNAs may be a promising therapeutic strategy for MS by regulating T lymphocyte function. By summarizing the recent literature, we reviewed the involvement of T lymphocytes in the pathogenesis of MS, the role of miRNAs in the pathogenesis and disease progression of MS by regulating T lymphocytes, the possibility of differentially expressed miRNAs to function as biomarkers for MS diagnosis, and the therapeutic potential of miRNAs in MS by regulating T lymphocytes.

摘要

微小RNA(miRNA)是一类具有调控活性的内源性非编码小RNA,通常在转录后水平调控靶基因的表达。多发性硬化症(MS)被认为是一种自身免疫介导的中枢神经系统(CNS)慢性炎性脱髓鞘疾病,典型地影响年轻人。T淋巴细胞在MS的发病机制中起重要作用,并且研究表明miRNA参与调控MS中T淋巴细胞的增殖、分化和功能维持。miRNA表达失调可能导致T淋巴细胞的分化平衡和功能障碍,因此它们参与了MS的发生和发展。此外,一些特定的miRNA,如miR-155和miR-326,可能对MS具有潜在的诊断价值或有助于区分MS的亚型。此外,miRNA可能通过调节T淋巴细胞功能成为MS的一种有前景的治疗策略。通过总结近期文献,我们综述了T淋巴细胞在MS发病机制中的作用、miRNA通过调节T淋巴细胞在MS发病机制和疾病进展中的作用、差异表达的miRNA作为MS诊断生物标志物的可能性以及miRNA通过调节T淋巴细胞在MS中的治疗潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/521d/9082748/10a2ff262bae/fnmol-15-865529-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/521d/9082748/10a2ff262bae/fnmol-15-865529-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/521d/9082748/10a2ff262bae/fnmol-15-865529-g001.jpg

相似文献

1
MicroRNAs as T Lymphocyte Regulators in Multiple Sclerosis.微小RNA作为多发性硬化症中T淋巴细胞的调节因子
Front Mol Neurosci. 2022 Apr 25;15:865529. doi: 10.3389/fnmol.2022.865529. eCollection 2022.
2
Small non-coding RNAs as important players, biomarkers and therapeutic targets in multiple sclerosis: A comprehensive overview.小非编码 RNA 作为多发性硬化症中的重要参与者、生物标志物和治疗靶点:全面综述。
J Autoimmun. 2019 Jul;101:17-25. doi: 10.1016/j.jaut.2019.04.002. Epub 2019 Apr 20.
3
Expression, regulation and function of microRNAs in multiple sclerosis.微小RNA在多发性硬化症中的表达、调控及功能
Int J Med Sci. 2014 Jun 2;11(8):810-8. doi: 10.7150/ijms.8647. eCollection 2014.
4
MicroRNA in multiple sclerosis.多发性硬化症中的微小RNA
Clin Chim Acta. 2021 May;516:92-99. doi: 10.1016/j.cca.2021.01.020. Epub 2021 Feb 2.
5
MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis.微小RNA-142在多发性硬化症动物模型中调节炎症和T细胞分化。
J Neuroinflammation. 2017 Mar 16;14(1):55. doi: 10.1186/s12974-017-0832-7.
6
Implication of genetic variants in primary microRNA processing sites in the risk of multiple sclerosis.遗传变异在原发性微 RNA 加工位点对多发性硬化症风险的影响。
EBioMedicine. 2022 Jun;80:104052. doi: 10.1016/j.ebiom.2022.104052. Epub 2022 May 10.
7
MicroRNA-29b variants and MxA expression change during interferon beta therapy in patients with relapsing-remitting multiple sclerosis.微小 RNA-29b 变体和 MxA 表达在复发缓解型多发性硬化症患者接受干扰素β治疗期间的变化。
Mult Scler Relat Disord. 2019 Oct;35:241-245. doi: 10.1016/j.msard.2019.07.034. Epub 2019 Jul 31.
8
Dysregulated Network of miRNAs Involved in the Pathogenesis of Multiple Sclerosis.miRNAs 失调网络参与多发性硬化症的发病机制。
Biomed Pharmacother. 2018 Aug;104:280-290. doi: 10.1016/j.biopha.2018.05.050. Epub 2018 May 25.
9
miRNA-Dependent CD4 T Cell Differentiation in the Pathogenesis of Multiple Sclerosis.微小RNA依赖的CD4 T细胞分化在多发性硬化症发病机制中的作用
Mult Scler Int. 2021 Jan 8;2021:8825588. doi: 10.1155/2021/8825588. eCollection 2021.
10
Dysregulated MicroRNA Involvement in Multiple Sclerosis by Induction of T Helper 17 Cell Differentiation.失调的微小RNA通过诱导辅助性T细胞17分化参与多发性硬化症。
Front Immunol. 2018 Jun 4;9:1256. doi: 10.3389/fimmu.2018.01256. eCollection 2018.

引用本文的文献

1
From Molecules to Models: miRNAs and Advanced Human Platforms of Neurodegeneration and Repair in Multiple Sclerosis.从分子到模型:微小RNA与多发性硬化症神经退行性变和修复的先进人类平台
Int J Mol Sci. 2025 Sep 8;26(17):8740. doi: 10.3390/ijms26178740.
2
A Literature Review and Meta-Analysis on the Potential Use of miR-150 as a Novel Biomarker in the Detection and Progression of Multiple Sclerosis.关于miR-150作为多发性硬化症检测和病情进展的新型生物标志物潜在用途的文献综述与荟萃分析
J Pers Med. 2024 Jul 31;14(8):815. doi: 10.3390/jpm14080815.
3
Multiple sclerosis disease activity, a multi-biomarker score of disease activity and response to treatment in multiple sclerosis.

本文引用的文献

1
NKT and NKT-like Cells in Autoimmune Neuroinflammatory Diseases-Multiple Sclerosis, Myasthenia Gravis and Guillain-Barre Syndrome.自身免疫性神经炎症性疾病中的自然杀伤 T 细胞和类自然杀伤 T 细胞——多发性硬化症、重症肌无力和吉兰-巴雷综合征。
Int J Mol Sci. 2021 Sep 1;22(17):9520. doi: 10.3390/ijms22179520.
2
PD-1/PD-L1 Axis as a Potential Therapeutic Target for Multiple Sclerosis: A T Cell Perspective.PD-1/PD-L1轴作为多发性硬化症的潜在治疗靶点:T细胞视角
Front Cell Neurosci. 2021 Jul 26;15:716747. doi: 10.3389/fncel.2021.716747. eCollection 2021.
3
miR-155 and functional proteins of CD8+ T cells as potential prognostic biomarkers for relapsing-remitting multiple sclerosis.
多发性硬化症疾病活动度,一种多发性硬化症疾病活动度和治疗反应的多生物标志物评分。
Front Immunol. 2024 Jun 27;15:1338585. doi: 10.3389/fimmu.2024.1338585. eCollection 2024.
4
MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review.微小RNA生物标志物作为神经退行性疾病的下一代诊断工具:综述
Front Mol Neurosci. 2024 May 31;17:1386735. doi: 10.3389/fnmol.2024.1386735. eCollection 2024.
5
MicroRNAs targeting TGF-β signaling exacerbate central nervous system autoimmunity by disrupting regulatory T cell development and function.靶向 TGF-β 信号的 microRNAs 通过破坏调节性 T 细胞的发育和功能来加剧中枢神经系统自身免疫。
Eur J Immunol. 2024 Jun;54(6):e2350548. doi: 10.1002/eji.202350548. Epub 2024 Apr 18.
6
A Dual Therapy of Nanostructured Lipid Carrier Loaded with Teriflunomide-A Dihydro-Orotate Dehydrogenase Inhibitor and an miR-155-Antagomir in Cuprizone-Induced C57BL/6J Mouse.载有特立氟胺(一种二氢乳清酸脱氢酶抑制剂)的纳米结构脂质载体与miR-155拮抗剂在铜螯合剂诱导的C57BL/6J小鼠中的双重疗法
Pharmaceutics. 2023 Apr 17;15(4):1254. doi: 10.3390/pharmaceutics15041254.
7
Dietary Polyphenols, Microbiome, and Multiple Sclerosis: From Molecular Anti-Inflammatory and Neuroprotective Mechanisms to Clinical Evidence.膳食多酚、微生物组与多发性硬化症:从分子抗炎和神经保护机制到临床证据。
Int J Mol Sci. 2023 Apr 14;24(8):7247. doi: 10.3390/ijms24087247.
8
Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target.多发性硬化症中的自身反应性淋巴细胞:发病机制和治疗靶点。
Front Immunol. 2022 Sep 23;13:996469. doi: 10.3389/fimmu.2022.996469. eCollection 2022.
miR-155 和 CD8+ T 细胞的功能蛋白作为复发性缓解型多发性硬化症的潜在预后生物标志物。
Mult Scler Relat Disord. 2021 Aug;53:103078. doi: 10.1016/j.msard.2021.103078. Epub 2021 Jun 11.
4
miRNAs Alter T Helper 17 Cell Fate in the Pathogenesis of Autoimmune Diseases.miRNAs 改变辅助性 T 细胞 17 细胞在自身免疫性疾病发病机制中的命运。
Front Immunol. 2021 Apr 21;12:593473. doi: 10.3389/fimmu.2021.593473. eCollection 2021.
5
Ponesimod modulates the Th1/Th17/Treg cell balance and ameliorates disease in experimental autoimmune encephalomyelitis.Ponesimod 调节 Th1/Th17/Treg 细胞平衡,改善实验性自身免疫性脑脊髓炎。
J Neuroimmunol. 2021 Jul 15;356:577583. doi: 10.1016/j.jneuroim.2021.577583. Epub 2021 Apr 23.
6
miRNA-467b inhibits Th17 differentiation by targeting eIF4E in experimental autoimmune encephalomyelitis.miRNA-467b 通过靶向 eIF4E 抑制实验性自身免疫性脑脊髓炎中的 Th17 分化。
Mol Immunol. 2021 May;133:23-33. doi: 10.1016/j.molimm.2021.02.008. Epub 2021 Feb 20.
7
Pregnancy-Induced Changes in microRNA Expression in Multiple Sclerosis.妊娠对多发性硬化症中 microRNA 表达的影响。
Front Immunol. 2021 Jan 28;11:552101. doi: 10.3389/fimmu.2020.552101. eCollection 2020.
8
miRNA-Dependent CD4 T Cell Differentiation in the Pathogenesis of Multiple Sclerosis.微小RNA依赖的CD4 T细胞分化在多发性硬化症发病机制中的作用
Mult Scler Int. 2021 Jan 8;2021:8825588. doi: 10.1155/2021/8825588. eCollection 2021.
9
Suppression of Experimental Autoimmune Encephalomyelitis by ILT3.Fc.ILT3.Fc 抑制实验性自身免疫性脑脊髓炎
J Immunol. 2021 Feb 1;206(3):554-565. doi: 10.4049/jimmunol.2000265. Epub 2020 Dec 23.
10
Kombucha ameliorates experimental autoimmune encephalomyelitis through activation of Treg and Th2 cells.康普茶通过激活 Treg 和 Th2 细胞来改善实验性自身免疫性脑脊髓炎。
Acta Neurol Belg. 2021 Dec;121(6):1685-1692. doi: 10.1007/s13760-020-01475-3. Epub 2020 Aug 18.